Back to Search
Start Over
Atezolizumab for PD-L1–Selected Patients with NSCLC
- Source :
- New England Journal of Medicine. 384:583-585
- Publication Year :
- 2021
- Publisher :
- Massachusetts Medical Society, 2021.
- Subjects :
- Oncology
medicine.medical_specialty
Lung Neoplasms
biology
business.industry
MEDLINE
General Medicine
Antibodies, Monoclonal, Humanized
medicine.disease
B7-H1 Antigen
Text mining
Atezolizumab
Carcinoma, Non-Small-Cell Lung
Internal medicine
PD-L1
Monoclonal
biology.protein
Carcinoma
medicine
Humans
Antibody
business
Subjects
Details
- ISSN :
- 15334406 and 00284793
- Volume :
- 384
- Database :
- OpenAIRE
- Journal :
- New England Journal of Medicine
- Accession number :
- edsair.doi.dedup.....9d2613518585f6d3cc3dc14669aae3c7
- Full Text :
- https://doi.org/10.1056/nejmc2032432